Scrutiny Slows Commercialization

A lower-probability path is that legal, safety, or diligence concerns slow Q Labs’ ability to monetize the result. Because the technology is still early-stage, these issues would mostly affect private valuation and partner timelines rather than broad markets.

Each figure is the modeled move of the S&P 500 if the outcome occurs. For information only. Not investment advice.